RNA Activation – MiNA Therapeutics | RNA Activation
MiNA Therapeutics is the global leader in small activating RNA (RNAa) therapeutics, harnessing innate mechanisms of gene activation to restore or boost normal gene function. The company advances a proprietary pipeline focused on genetic medicine while collaborating with leading pharmaceutical companies including Eli Lilly to apply its RNAa platform across a broad range of therapeutic areas.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2023
Jul 2021
Sep 2020
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
